Alterity Therapeutics (ATHE) Stock Highlights

2.2 | +4.76%

2024-12-21 07:41:07

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimers disease, Huntington disease, and other neurodegenerative disorders. The companys lead drug candidate-PBT2 is being developed for the treatment of Alzheimers and Huntingtons diseases. It has also advanced a drug candidate for Parkinsons disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Statistics

Range Today

2.05 2.25

Volume Today 26.5K

Range 1 Year

1 3.19

Volume 1 Year 12.37M

Range 3 Year

1 12.3

Volume 3 Year 69.32M

Range 10 Year

1 112.2

Volume 10 Year 177.86M

Highlights

Market Capitalization 10.51M (micro)

Floating Shares 3.73B

Current Price 2.2

Price To Earnings -0.6

Price To Revenue 1.53K

Price To Book 386.67

Earnings Per Share -2.03

Payout Ratio 0%

Performance

Latest +4.76%

1 Month +100%

3 Months +81.82%

6 Months +14.58%

1 Year -21.15%

3 Years -73.81%

5 Years -79.63%

10 Years -98.02%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.